PTO grants interim Angiomax extension

The U.S. Patent and Trademark Office granted a one-year, interim extension for a patent covering anticoagulant Angiomax bivalirudin from The Medicines Co. (NASDAQ:MDCO) until Aug. 31, 2011. The decisi...